Review
doi: 10.1038/s41575-020-00410-4.
The war against pancreatic cancer in 2020 - advances on all fronts
Affiliations
- PMID: 33414515
- DOI: 10.1038/s41575-020-00410-4
Item in Clipboard
Review
The war against pancreatic cancer in 2020 - advances on all fronts
Nat Rev Gastroenterol Hepatol.
2021 Feb.
No abstract available
Similar articles
-
Single-Cell RNA Sequencing Reveals Stromal Evolution into LRRC15+ Myofibroblasts as a Determinant of Patient Response to Cancer Immunotherapy.Cancer Discov. 2020 Feb;10(2):232-253. doi: 10.1158/2159-8290.CD-19-0644. Epub 2019 Nov 7. Cancer Discov. 2020. PMID: 31699795
-
Microsatellite instability/mismatch repair deficiency in pancreatic cancers: the same or different?Gut. 2021 Oct;70(10):1809-1811. doi: 10.1136/gutjnl-2020-323805. Epub 2021 Jan 19. Gut. 2021. PMID: 33468535 No abstract available.
-
Brca2 deficiency and Trp53 deregulation in pancreatic cancer: implications for therapeutic targeting.Cancer Biol Ther. 2011 Jun 1;11(11):969-73. doi: 10.4161/cbt.11.11.16573. Epub 2011 Jun 1. Cancer Biol Ther. 2011. PMID: 21610317 No abstract available.
-
Fibroblasts in Pancreatic Ductal Adenocarcinoma: Biological Mechanisms and Therapeutic Targets.Gastroenterology. 2019 May;156(7):2085-2096. doi: 10.1053/j.gastro.2018.12.044. Epub 2019 Feb 2. Gastroenterology. 2019. PMID: 30721663 Free PMC article. Review.
-
Therapeutic resistance of pancreatic cancer: Roadmap to its reversal.Biochim Biophys Acta Rev Cancer. 2021 Jan;1875(1):188461. doi: 10.1016/j.bbcan.2020.188461. Epub 2020 Nov 4. Biochim Biophys Acta Rev Cancer. 2021. PMID: 33157162 Review.
Cited by
-
Synergistic effect of Abraxane that combines human IL15 fused with an albumin-binding domain on murine models of pancreatic ductal adenocarcinoma.J Cell Mol Med. 2022 Apr;26(7):1955-1968. doi: 10.1111/jcmm.17220. Epub 2022 Feb 17. J Cell Mol Med. 2022. PMID: 35174623 Free PMC article.
-
Orexins: A promising target to digestive cancers, inflammation, obesity and metabolism dysfunctions.World J Gastroenterol. 2021 Nov 28;27(44):7582-7596. doi: 10.3748/wjg.v27.i44.7582. World J Gastroenterol. 2021. PMID: 34908800 Free PMC article. Review.
-
The deubiquitinating enzyme MINDY2 promotes pancreatic cancer proliferation and metastasis by stabilizing ACTN4 expression and activating the PI3K/AKT/mTOR signaling pathway.Front Oncol. 2023 May 3;13:1169833. doi: 10.3389/fonc.2023.1169833. eCollection 2023. Front Oncol. 2023. PMID: 37207150 Free PMC article.
-
Immunosuppression, immune escape, and immunotherapy in pancreatic cancer: focused on the tumor microenvironment.Cell Oncol (Dordr). 2023 Feb;46(1):17-48. doi: 10.1007/s13402-022-00741-1. Epub 2022 Nov 11. Cell Oncol (Dordr). 2023. PMID: 36367669 Review.
-
Keratin19 promotes pancreatic cancer progression and poor prognosis via activating the Hedgehog pathway.Int J Oncol. 2023 Mar;62(3):43. doi: 10.3892/ijo.2023.5491. Epub 2023 Feb 24. Int J Oncol. 2023. PMID: 36825581 Free PMC article.
References
-
- Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394–424 (2018).
-
- Strobel, O. et al. Optimizing the outcomes of pancreatic cancer surgery. Nat. Rev. Clin. Oncol. 16, 11–26 (2019). - DOI
-
- Zhou, B. et al. Obesity and pancreatic cancer: an update of epidemiological evidence and molecular mechanisms. Pancreatology 19, 941–950 (2019). - DOI
-
- Chung, K. M. et al. Endocrine-exocrine signaling drives obesity-associated pancreatic ductal adenocarcinoma. Cell 181, 832–847 (2020). - DOI
-
- Garg, B. et al. NFκB in pancreatic stellate cells reduces infiltration of tumors by cytotoxic T cells and killing of cancer cells, via up-regulation of CXCL12. Gastroenterology 155, 880–891 (2018). - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
